肾脏替代治疗模式与终末期肾病卒中风险:一项全国注册研究
该研究利用苏格兰肾脏注册和卒中审计数据,纳入2005至2013年起始肾脏替代治疗的4957例成人ESRD患者,分析卒中发生率及与治疗模式的关系。结果显示卒中发生率为18.6/1000患者年,起始模式与卒中风险无关,但时间依赖分析中血液透析暴露独立增加卒中风险,腹膜透析调整后未增加风险。
要点
- ESRD患者卒中发生率为18.6/1000患者年。
- 起始RRT模式与卒中风险无关,但血液透析暴露独立增加风险。
- 腹膜透析调整后未增加卒中风险,移植为参照。
核心结论
- 在起始RRT的ESRD患者中,血液透析使用独立增加卒中风险,而腹膜透析调整后未增加风险。
研究设计与样本
- 基于苏格兰肾脏注册和苏格兰卒中审计的注册研究,纳入2005至2013年起始RRT的4957例成人ESRD患者,中位年龄64.5岁,女性占41.5%。
主要发现
- 277例患者发生卒中,发生率为18.6/1000患者年。
- 卒中患者年龄更大、血压更高,更可能为女性及患有糖尿病。
- 多变量回归中,年龄较大、女性、糖尿病和较高血磷与卒中风险相关,起始RRT模式无关联。
- 时间依赖分析中,血液透析暴露独立与卒中风险增加相关。
临床怎么用
- 在ESRD患者选择RRT模式时,需考虑血液透析可能增加卒中风险,腹膜透析调整后未显示增加风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of stroke in end-stage renal disease (ESRD) on renal replacement therapy (RRT) is up to 10-fold greater than the general population. However, whether this increased risk differs by RRT modality is unclear. METHODS: We used data contained in the Scottish Renal Registry and the Scottish Stroke Care Audit to identify stroke in all adult patients who commenced RRT for ESRD from 2005 to 2013. Incidence rate was calculated and regression analyses were performed to identify variables associated with stroke. We explored the effect of RRT modality at initiation and cumulative dialysis exposure by time-dependent regression analysis, using transplant recipients as the reference group. RESULTS: A total of 4957 patients commenced RRT for ESRD. Median age was 64.5 years, 41.5% were female and 277 patients suffered a stroke (incidence rate was 18.6/1000 patient-years). Patients who had stroke were older, had higher blood pressure and were more likely to be female and have diabetes. On multivariable regression older age, female sex, diabetes and higher serum phosphate were associated with risk of stroke. RRT modality at initiation was not. On time-dependent analysis, haemodialysis (HD) exposure was independently associated with increased risk of stroke. CONCLUSIONS: In patients with ESRD who initiate RRT, HD use independently increases risk of stroke compared with transplantation. Use of peritoneal dialysis did not increase risk on adjusted analysis.
引用
- Findlay M, MacIsaac R, MacLeod MJ, et al. Renal replacement modality and stroke risk in end-stage renal disease-a national registry study. Nephrol Dial Transplant. 2018. PMID: 29069522. doi:10.1093/ndt/gfx291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。